You just read:

Jupiter Orphan Therapeutics Receives Orphan Drug Designation for its Trans-Resveratrol Product JOTROL for Treatment of Friedreich's Ataxia

News provided by

Jupiter Orphan Therapeutics, Inc.

Aug 22, 2017, 08:45 ET